Radioembulization Y91 Santa Fe
Radioembolization, also known as Yttrium-90 (Y90) or transarterial radioembolization (TARE), is a minimally invasive treatment option for liver cancer. The procedure involves the injection of small beads, called microspheres, that contain a radioactive material called yttrium-90 (Y90) directly into the liver tumor. The microspheres are delivered through a catheter placed in the hepatic artery, which supplies blood to the liver. Once in the tumor, the radioactive material in the microspheres destroys the cancer cells while minimizing damage to the surrounding healthy tissue.

What Is Radioembulization Y91 Santa Fe:

Y90 radioembolization is typically used for patients with unresectable liver tumors, meaning the tumors cannot be surgically removed. This may include patients with advanced primary liver cancer or metastatic cancer that has spread to the liver from another location in the body. The procedure is typically performed as a treatment option when other treatments such as chemotherapy and radiation therapy are not effective.

The procedure is usually done as an outpatient procedure, in some cases, it can be done under sedation, but it could be done under general anesthesia. Before the procedure, the patient will have an imaging test such as a CT scan or MRI to determine the location and size of the tumor. The patient’s blood will also be tested to ensure their liver function is adequate for the procedure.

During the procedure, the patient will lie on an examination table and a small catheter will be inserted into the hepatic artery through a small incision made in the femoral or radial artery. The catheter is then guided to the liver tumor and the microspheres are delivered through the catheter. The procedure usually takes about 1-2 hours to complete.

What We Should Know About The Radioembulization Y91 Santa Fe:

After the procedure, the patient will be monitored for any complications, such as bleeding or infection. They will also have regular imaging tests to monitor the response of the tumor to the treatment. The patient may experience some side effects such as abdominal pain, nausea, and fatigue, but these are usually temporary and can be managed with medication.

Y90 radioembolization has been shown to be effective in treating liver cancer. Studies have shown that the procedure can shrink or stabilize tumors in up to 80% of patients. It also has a relatively low risk of serious side effects and can be repeated if necessary.

The radioembolization Y91 Santa Fe is offered by one of the most prestigious centers in the area. They have a team of specialists with a wide range of expertise and experience in the field of interventional radiology, oncology, and radiation therapy. They use the latest technology and techniques to provide the best possible care to their patients.

Radioembulization Y91 Santa Fe How Its Work?
Radioembolization, also known as Yttrium-90 (Y90) or transarterial radioembolization (TARE), is a minimally invasive treatment option for liver cancer. The procedure works by delivering small beads, called microspheres, that contain a radioactive material called yttrium-90 (Y90) directly into the liver tumor. The microspheres are delivered through a catheter placed in the hepatic artery, which supplies blood to the liver.

The procedure begins with imaging tests such as a CT scan or MRI to determine the location and size of the tumor. This helps the interventional radiologist to plan the procedure. The patient will be given general or conscious sedation to help them relax and feel comfortable during the procedure. A small incision is made in the femoral or radial artery and a catheter is inserted into the hepatic artery, which is then guided to the liver tumor.

Once the catheter is in place, the microspheres are delivered through the catheter and into the tumor. The radioactive material in the microspheres targets the cancer cells and destroys them, while minimizing damage to the surrounding healthy tissue. The procedure usually takes about 1-2 hours to complete.

After the procedure, the patient will be monitored for any complications and will have regular imaging tests to monitor the response of the tumor to the treatment. The patient may experience some side effects such as abdominal pain, nausea, and fatigue, but these are usually temporary and can be managed with medication.

Radioembulization Y91 Santa Fe:

In summary, Y90 radioembolization is a minimally invasive treatment option for patients with unresectable liver tumors. The procedure involves the injection of microspheres containing a radioactive material directly into the tumor, which destroys the cancer cells while minimizing damage to the surrounding healthy tissue. The procedure is performed by interventional radiologist, under imaging guidance, using a catheter inserted in the hepatic artery that is guided to the tumor, the microspheres are then delivered into the tumor, the radioactive material in the microspheres targets the cancer cells and destroys them. The procedure is typically performed as a treatment option when other treatments such as chemotherapy and radiation therapy are not effective and is available in Santa Fe.

If you want to get amazing benefits by using this link

Radioembulization Y90 Santa Fe

Mri scan

Prostate Imaging Farmington

Dialysis Access

Conclusion:

In conclusion, Y90 radioembolization is a minimally invasive treatment option for patients with unresectable liver tumors. The procedure involves the injection of microspheres containing radioactive material directly into the tumor, which destroys the cancer cells while minimizing damage to the surrounding healthy tissue. The procedure is typically performed as a treatment option when other treatments such as chemotherapy and radiation therapy are not effective. Y90 radioembolization is an effective treatment option with a low risk of serious side effects and is available in Santa Fe at one of the most prestigious centers in the area.

Leave a Reply

Your email address will not be published. Required fields are marked *